论文部分内容阅读
ＮｉｔｒｏＭｅｄ公司报道了ＮＭＩ－８７０用于治疗女性性 欲唤起障碍Ⅱ期临床研究结果。本品是ａ２阻滞剂育 亨宾（ｙｏｈｉｍｂｉｎｅ）的氧化氮增强剂。在２４例患该病的 绝经后妇女中，本品较安慰剂或育亨宾单用能更好 地增加阴道血流。本品用于男性勃起功能障碍的Ⅰ／ Ⅱ
NitroMed company reported NMI-870 for the treatment of female sexual arousal disorder Ⅱ clinical results. This product is a2 blockers yohimbine nitrogen oxide enhancer. In 24 patients with the disease of postmenopausal women, the goods than placebo or yohimbine alone can better increase vaginal blood flow. This product is used for male erectile dysfunction Ⅰ / Ⅱ